Systemic Camkk2 ablation slowed disease progression in the TRAMP GEMM of prostate cancer (Figure 1) similar to what was observed in the Pb-Cre4;Ptenf/f GEMM of prostate cancer [12]. Here, CAMKK2 is linked to prostate carcinoma.